![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1996-3181|8|6|440-450
ISSN: 1871-5273
Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.8, Iss.6, 2009-12, pp. : 440-450
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cholinergic receptors and neurodegenerative diseases
By Gualtieri F.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chelating Agents for Neurodegenerative Diseases
Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenomics of neurodegenerative diseases
By Maimone D. Dominici R. Grimaldi L.M.E.
European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Receptors in neurodegenerative diseases
By Froestl W.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :